Additionally, a previous study has shown that miR-498 targets ZEB2 to inhibit invasion, migration, and proliferation in liver cancer cells (Zhang et al., 2019), suggesting that the level of ZEB2 is abnormal in some diseases, including liver disease. This evidence concerns the gene ZEB2 and liver disorder.